New Delhi: The phase III trials of the Oxford vaccine for COVID-19 are likely to start this week in India. According to a report in India Today TV, the trials ...
Moscow: A top Russian health official has said that the COVID-19 vaccine developed by the country is recommended to be used for individuals from 18 to 60 years as of ...
New Delhi: Russian President Vladimir Putin’s announcement of the statutory approval of the COVID-19 vaccine for public use on Tuesday has stunned the world and raised several eyebrows. Dr Randeep ...
New Delhi: The local association of multinational pharmaceutical companies says Russia’s hurry to allow civilian use of a potential COVID-19 vaccine even before its clinical trial could put people at ...
Mumbai: Serum Institute of India (SII) will make the COVID-19 vaccine available for $3 per dose to low and middle-income countries (LMIC) including India. The world’s largest vaccine manufacturer by ...
Pharmaceutical giant AstraZeneca has promised not to profit from its COVID-19 vaccine, developed in partnership with Oxford University, during the pandemic as the company reported it was on track with ...
New Delhi: Anja Karliczek, German Research Minister, said it’s unlikely that the world will get a vaccine for the COVID-19 for public use before mid-2021. At a press conference in ...
New Delhi: Russia is targeting to be the first country in the world to approve a coronavirus vaccine to be used widely in less than two weeks’ time despite safety ...
Mumbai: After reports of a fallout between Kartik Aaryan and Bhushan Kumar started doing the rounds earlier in the day, the actor and the T-series honcho took to their official ...
New Delhi: Although India is not expecting a COVID-19 vaccine until early next year and the government has not yet signed any agreement with companies that are developing the vaccine, ...
Copyright © 2024 Frontier Media
